nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP2C19—coronary artery disease	0.212	1	CbGaD
Methimazole—CYP2B6—Clopidogrel—coronary artery disease	0.03	0.0534	CbGbCtD
Methimazole—CYP2C9—Fenofibrate—coronary artery disease	0.0229	0.0407	CbGbCtD
Methimazole—CYP2C19—Gemfibrozil—coronary artery disease	0.022	0.0391	CbGbCtD
Methimazole—CYP1A2—Gemfibrozil—coronary artery disease	0.0203	0.0361	CbGbCtD
Methimazole—CYP2C19—Clopidogrel—coronary artery disease	0.0191	0.0339	CbGbCtD
Methimazole—CYP2C9—Gemfibrozil—coronary artery disease	0.0183	0.0325	CbGbCtD
Methimazole—CYP2B6—Simvastatin—coronary artery disease	0.018	0.032	CbGbCtD
Methimazole—CYP1A2—Clopidogrel—coronary artery disease	0.0176	0.0313	CbGbCtD
Methimazole—CYP2C19—Telmisartan—coronary artery disease	0.0167	0.0296	CbGbCtD
Methimazole—CYP2B6—Atorvastatin—coronary artery disease	0.016	0.0285	CbGbCtD
Methimazole—CYP2C9—Clopidogrel—coronary artery disease	0.0159	0.0282	CbGbCtD
Methimazole—CYP3A4—Ticagrelor—coronary artery disease	0.0149	0.0265	CbGbCtD
Methimazole—CYP2C9—Pitavastatin—coronary artery disease	0.0139	0.0246	CbGbCtD
Methimazole—CYP2C9—Valsartan—coronary artery disease	0.0135	0.024	CbGbCtD
Methimazole—CYP2C19—Timolol—coronary artery disease	0.0134	0.0239	CbGbCtD
Methimazole—CYP3A4—Fenofibrate—coronary artery disease	0.0133	0.0236	CbGbCtD
Methimazole—CYP2C19—Rosuvastatin—coronary artery disease	0.0123	0.0218	CbGbCtD
Methimazole—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.012	0.0213	CbGbCtD
Methimazole—CYP2C19—Simvastatin—coronary artery disease	0.0114	0.0203	CbGbCtD
Methimazole—CYP2C19—Lovastatin—coronary artery disease	0.0112	0.0199	CbGbCtD
Methimazole—CYP2D6—Niacin—coronary artery disease	0.011	0.0195	CbGbCtD
Methimazole—CYP3A4—Gemfibrozil—coronary artery disease	0.0106	0.0189	CbGbCtD
Methimazole—CYP2C9—Rosuvastatin—coronary artery disease	0.0102	0.0182	CbGbCtD
Methimazole—CYP2D6—Timolol—coronary artery disease	0.0102	0.0182	CbGbCtD
Methimazole—CYP2C19—Atorvastatin—coronary artery disease	0.0102	0.0181	CbGbCtD
Methimazole—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00996	0.0177	CbGbCtD
Methimazole—CYP2C9—Simvastatin—coronary artery disease	0.0095	0.0169	CbGbCtD
Methimazole—CYP2C19—Losartan—coronary artery disease	0.00931	0.0166	CbGbCtD
Methimazole—CYP2C9—Pravastatin—coronary artery disease	0.0093	0.0165	CbGbCtD
Methimazole—CYP2C9—Lovastatin—coronary artery disease	0.0093	0.0165	CbGbCtD
Methimazole—CYP3A4—Clopidogrel—coronary artery disease	0.00922	0.0164	CbGbCtD
Methimazole—CYP2D6—Captopril—coronary artery disease	0.00899	0.016	CbGbCtD
Methimazole—CYP2D6—Simvastatin—coronary artery disease	0.00869	0.0154	CbGbCtD
Methimazole—CYP1A2—Losartan—coronary artery disease	0.00859	0.0153	CbGbCtD
Methimazole—CYP3A4—Eplerenone—coronary artery disease	0.00857	0.0152	CbGbCtD
Methimazole—CYP2D6—Pravastatin—coronary artery disease	0.0085	0.0151	CbGbCtD
Methimazole—CYP2D6—Lovastatin—coronary artery disease	0.0085	0.0151	CbGbCtD
Methimazole—CYP2C9—Atorvastatin—coronary artery disease	0.00847	0.015	CbGbCtD
Methimazole—CYP2C9—Losartan—coronary artery disease	0.00774	0.0138	CbGbCtD
Methimazole—CYP2D6—Atorvastatin—coronary artery disease	0.00774	0.0138	CbGbCtD
Methimazole—CYP3A4—Enalapril—coronary artery disease	0.00764	0.0136	CbGbCtD
Methimazole—CYP3A4—Rosuvastatin—coronary artery disease	0.00594	0.0106	CbGbCtD
Methimazole—CYP3A4—Ezetimibe—coronary artery disease	0.00594	0.0106	CbGbCtD
Methimazole—CYP3A4—Simvastatin—coronary artery disease	0.00552	0.00982	CbGbCtD
Methimazole—CYP3A4—Lovastatin—coronary artery disease	0.00541	0.00961	CbGbCtD
Methimazole—CYP3A4—Pravastatin—coronary artery disease	0.00541	0.00961	CbGbCtD
Methimazole—CYP3A4—Atorvastatin—coronary artery disease	0.00492	0.00875	CbGbCtD
Methimazole—CYP3A4—Losartan—coronary artery disease	0.0045	0.008	CbGbCtD
Methimazole—Thrombocytopenia—Trandolapril—coronary artery disease	0.000233	0.00157	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Olmesartan—coronary artery disease	0.000232	0.00156	CcSEcCtD
Methimazole—Thrombocytopenia—Enalapril—coronary artery disease	0.000232	0.00156	CcSEcCtD
Methimazole—Urticaria—Clopidogrel—coronary artery disease	0.000232	0.00156	CcSEcCtD
Methimazole—Nausea—Gemfibrozil—coronary artery disease	0.000231	0.00156	CcSEcCtD
Methimazole—Body temperature increased—Clopidogrel—coronary artery disease	0.000231	0.00155	CcSEcCtD
Methimazole—Arthralgia—Perindopril—coronary artery disease	0.00023	0.00155	CcSEcCtD
Methimazole—Myalgia—Perindopril—coronary artery disease	0.00023	0.00155	CcSEcCtD
Methimazole—Urticaria—Lovastatin—coronary artery disease	0.00023	0.00155	CcSEcCtD
Methimazole—Paraesthesia—Valsartan—coronary artery disease	0.00023	0.00155	CcSEcCtD
Methimazole—Body temperature increased—Lovastatin—coronary artery disease	0.000229	0.00154	CcSEcCtD
Methimazole—Thrombocytopenia—Telmisartan—coronary artery disease	0.000229	0.00154	CcSEcCtD
Methimazole—Vertigo—Losartan—coronary artery disease	0.000228	0.00154	CcSEcCtD
Methimazole—Somnolence—Valsartan—coronary artery disease	0.000228	0.00153	CcSEcCtD
Methimazole—Leukopenia—Losartan—coronary artery disease	0.000227	0.00153	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Niacin—coronary artery disease	0.000227	0.00153	CcSEcCtD
Methimazole—Hepatitis—Lisinopril—coronary artery disease	0.000227	0.00153	CcSEcCtD
Methimazole—Urticaria—Ezetimibe—coronary artery disease	0.000226	0.00152	CcSEcCtD
Methimazole—Nausea—Ticagrelor—coronary artery disease	0.000226	0.00152	CcSEcCtD
Methimazole—Dyspepsia—Valsartan—coronary artery disease	0.000225	0.00152	CcSEcCtD
Methimazole—Body temperature increased—Ezetimibe—coronary artery disease	0.000225	0.00151	CcSEcCtD
Methimazole—Dyspepsia—Olmesartan—coronary artery disease	0.000224	0.00151	CcSEcCtD
Methimazole—Paraesthesia—Niacin—coronary artery disease	0.000224	0.00151	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Pravastatin—coronary artery disease	0.000223	0.0015	CcSEcCtD
Methimazole—Thrombocytopenia—Captopril—coronary artery disease	0.000223	0.0015	CcSEcCtD
Methimazole—Somnolence—Niacin—coronary artery disease	0.000221	0.00149	CcSEcCtD
Methimazole—Alopecia—Ramipril—coronary artery disease	0.000221	0.00149	CcSEcCtD
Methimazole—Oedema—Perindopril—coronary artery disease	0.000221	0.00149	CcSEcCtD
Methimazole—Paraesthesia—Pravastatin—coronary artery disease	0.00022	0.00148	CcSEcCtD
Methimazole—Body temperature increased—Eplerenone—coronary artery disease	0.00022	0.00148	CcSEcCtD
Methimazole—Dyspepsia—Niacin—coronary artery disease	0.000219	0.00148	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Trandolapril—coronary artery disease	0.000217	0.00146	CcSEcCtD
Methimazole—Thrombocytopenia—Perindopril—coronary artery disease	0.000216	0.00146	CcSEcCtD
Methimazole—Arthralgia—Losartan—coronary artery disease	0.000216	0.00146	CcSEcCtD
Methimazole—Myalgia—Losartan—coronary artery disease	0.000216	0.00146	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Enalapril—coronary artery disease	0.000216	0.00146	CcSEcCtD
Methimazole—Alopecia—Timolol—coronary artery disease	0.000216	0.00145	CcSEcCtD
Methimazole—Dyspepsia—Pravastatin—coronary artery disease	0.000216	0.00145	CcSEcCtD
Methimazole—Rash—Rosuvastatin—coronary artery disease	0.000216	0.00145	CcSEcCtD
Methimazole—Dermatitis—Rosuvastatin—coronary artery disease	0.000215	0.00145	CcSEcCtD
Methimazole—Urticaria—Simvastatin—coronary artery disease	0.000215	0.00145	CcSEcCtD
Methimazole—Body temperature increased—Simvastatin—coronary artery disease	0.000214	0.00144	CcSEcCtD
Methimazole—Headache—Rosuvastatin—coronary artery disease	0.000214	0.00144	CcSEcCtD
Methimazole—Paraesthesia—Trandolapril—coronary artery disease	0.000214	0.00144	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Telmisartan—coronary artery disease	0.000213	0.00144	CcSEcCtD
Methimazole—Paraesthesia—Enalapril—coronary artery disease	0.000213	0.00143	CcSEcCtD
Methimazole—Somnolence—Trandolapril—coronary artery disease	0.000212	0.00143	CcSEcCtD
Methimazole—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000211	0.00142	CcSEcCtD
Methimazole—Somnolence—Enalapril—coronary artery disease	0.000211	0.00142	CcSEcCtD
Methimazole—Thrombocytopenia—Furosemide—coronary artery disease	0.00021	0.00142	CcSEcCtD
Methimazole—Pruritus—Fenofibrate—coronary artery disease	0.00021	0.00142	CcSEcCtD
Methimazole—Paraesthesia—Telmisartan—coronary artery disease	0.00021	0.00141	CcSEcCtD
Methimazole—Dyspepsia—Trandolapril—coronary artery disease	0.00021	0.00141	CcSEcCtD
Methimazole—Rash—Acetylsalicylic acid—coronary artery disease	0.000209	0.00141	CcSEcCtD
Methimazole—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000209	0.00141	CcSEcCtD
Methimazole—Dyspepsia—Enalapril—coronary artery disease	0.000209	0.00141	CcSEcCtD
Methimazole—Somnolence—Telmisartan—coronary artery disease	0.000208	0.0014	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Captopril—coronary artery disease	0.000207	0.0014	CcSEcCtD
Methimazole—Oedema—Losartan—coronary artery disease	0.000207	0.0014	CcSEcCtD
Methimazole—Pruritus—Clopidogrel—coronary artery disease	0.000206	0.00139	CcSEcCtD
Methimazole—Dyspepsia—Telmisartan—coronary artery disease	0.000206	0.00139	CcSEcCtD
Methimazole—Pruritus—Lovastatin—coronary artery disease	0.000205	0.00138	CcSEcCtD
Methimazole—Paraesthesia—Captopril—coronary artery disease	0.000204	0.00138	CcSEcCtD
Methimazole—Urticaria—Valsartan—coronary artery disease	0.000203	0.00137	CcSEcCtD
Methimazole—Nausea—Rosuvastatin—coronary artery disease	0.000203	0.00137	CcSEcCtD
Methimazole—Thrombocytopenia—Losartan—coronary artery disease	0.000203	0.00137	CcSEcCtD
Methimazole—Urticaria—Olmesartan—coronary artery disease	0.000202	0.00136	CcSEcCtD
Methimazole—Somnolence—Captopril—coronary artery disease	0.000202	0.00136	CcSEcCtD
Methimazole—Body temperature increased—Olmesartan—coronary artery disease	0.000201	0.00136	CcSEcCtD
Methimazole—Pruritus—Ezetimibe—coronary artery disease	0.000201	0.00136	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Perindopril—coronary artery disease	0.000201	0.00136	CcSEcCtD
Methimazole—Alopecia—Lisinopril—coronary artery disease	0.0002	0.00135	CcSEcCtD
Methimazole—Dyspepsia—Captopril—coronary artery disease	0.0002	0.00135	CcSEcCtD
Methimazole—Paraesthesia—Perindopril—coronary artery disease	0.000198	0.00134	CcSEcCtD
Methimazole—Urticaria—Niacin—coronary artery disease	0.000198	0.00133	CcSEcCtD
Methimazole—Nausea—Acetylsalicylic acid—coronary artery disease	0.000197	0.00133	CcSEcCtD
Methimazole—Pruritus—Eplerenone—coronary artery disease	0.000197	0.00133	CcSEcCtD
Methimazole—Body temperature increased—Niacin—coronary artery disease	0.000197	0.00133	CcSEcCtD
Methimazole—Somnolence—Perindopril—coronary artery disease	0.000196	0.00132	CcSEcCtD
Methimazole—Vertigo—Ramipril—coronary artery disease	0.000195	0.00132	CcSEcCtD
Methimazole—Leukopenia—Ramipril—coronary artery disease	0.000195	0.00131	CcSEcCtD
Methimazole—Urticaria—Pravastatin—coronary artery disease	0.000195	0.00131	CcSEcCtD
Methimazole—Dyspepsia—Perindopril—coronary artery disease	0.000194	0.00131	CcSEcCtD
Methimazole—Body temperature increased—Pravastatin—coronary artery disease	0.000194	0.00131	CcSEcCtD
Methimazole—Paraesthesia—Furosemide—coronary artery disease	0.000193	0.0013	CcSEcCtD
Methimazole—Pruritus—Simvastatin—coronary artery disease	0.000192	0.00129	CcSEcCtD
Methimazole—Vertigo—Timolol—coronary artery disease	0.000191	0.00129	CcSEcCtD
Methimazole—Somnolence—Furosemide—coronary artery disease	0.000191	0.00129	CcSEcCtD
Methimazole—Urticaria—Trandolapril—coronary artery disease	0.000189	0.00127	CcSEcCtD
Methimazole—Vomiting—Fenofibrate—coronary artery disease	0.000189	0.00127	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000189	0.00127	CcSEcCtD
Methimazole—Urticaria—Enalapril—coronary artery disease	0.000188	0.00127	CcSEcCtD
Methimazole—Body temperature increased—Trandolapril—coronary artery disease	0.000188	0.00127	CcSEcCtD
Methimazole—Body temperature increased—Enalapril—coronary artery disease	0.000187	0.00126	CcSEcCtD
Methimazole—Rash—Fenofibrate—coronary artery disease	0.000187	0.00126	CcSEcCtD
Methimazole—Dermatitis—Fenofibrate—coronary artery disease	0.000187	0.00126	CcSEcCtD
Methimazole—Headache—Fenofibrate—coronary artery disease	0.000186	0.00125	CcSEcCtD
Methimazole—Paraesthesia—Losartan—coronary artery disease	0.000186	0.00125	CcSEcCtD
Methimazole—Urticaria—Telmisartan—coronary artery disease	0.000186	0.00125	CcSEcCtD
Methimazole—Vomiting—Clopidogrel—coronary artery disease	0.000186	0.00125	CcSEcCtD
Methimazole—Arthralgia—Ramipril—coronary artery disease	0.000185	0.00125	CcSEcCtD
Methimazole—Myalgia—Ramipril—coronary artery disease	0.000185	0.00125	CcSEcCtD
Methimazole—Body temperature increased—Telmisartan—coronary artery disease	0.000185	0.00125	CcSEcCtD
Methimazole—Vomiting—Lovastatin—coronary artery disease	0.000184	0.00124	CcSEcCtD
Methimazole—Somnolence—Losartan—coronary artery disease	0.000184	0.00124	CcSEcCtD
Methimazole—Rash—Clopidogrel—coronary artery disease	0.000184	0.00124	CcSEcCtD
Methimazole—Dermatitis—Clopidogrel—coronary artery disease	0.000184	0.00124	CcSEcCtD
Methimazole—Headache—Clopidogrel—coronary artery disease	0.000183	0.00123	CcSEcCtD
Methimazole—Rash—Lovastatin—coronary artery disease	0.000183	0.00123	CcSEcCtD
Methimazole—Dermatitis—Lovastatin—coronary artery disease	0.000183	0.00123	CcSEcCtD
Methimazole—Dyspepsia—Losartan—coronary artery disease	0.000182	0.00123	CcSEcCtD
Methimazole—Headache—Lovastatin—coronary artery disease	0.000182	0.00122	CcSEcCtD
Methimazole—Pruritus—Valsartan—coronary artery disease	0.000181	0.00122	CcSEcCtD
Methimazole—Arthralgia—Timolol—coronary artery disease	0.000181	0.00122	CcSEcCtD
Methimazole—Myalgia—Timolol—coronary artery disease	0.000181	0.00122	CcSEcCtD
Methimazole—Vomiting—Ezetimibe—coronary artery disease	0.000181	0.00122	CcSEcCtD
Methimazole—Pruritus—Olmesartan—coronary artery disease	0.00018	0.00121	CcSEcCtD
Methimazole—Body temperature increased—Captopril—coronary artery disease	0.00018	0.00121	CcSEcCtD
Methimazole—Rash—Ezetimibe—coronary artery disease	0.000179	0.00121	CcSEcCtD
Methimazole—Dermatitis—Ezetimibe—coronary artery disease	0.000179	0.00121	CcSEcCtD
Methimazole—Headache—Ezetimibe—coronary artery disease	0.000178	0.0012	CcSEcCtD
Methimazole—Oedema—Ramipril—coronary artery disease	0.000178	0.0012	CcSEcCtD
Methimazole—Vertigo—Lisinopril—coronary artery disease	0.000177	0.00119	CcSEcCtD
Methimazole—Vomiting—Eplerenone—coronary artery disease	0.000177	0.00119	CcSEcCtD
Methimazole—Leukopenia—Lisinopril—coronary artery disease	0.000177	0.00119	CcSEcCtD
Methimazole—Nausea—Fenofibrate—coronary artery disease	0.000176	0.00119	CcSEcCtD
Methimazole—Pruritus—Niacin—coronary artery disease	0.000176	0.00119	CcSEcCtD
Methimazole—Rash—Eplerenone—coronary artery disease	0.000175	0.00118	CcSEcCtD
Methimazole—Urticaria—Perindopril—coronary artery disease	0.000175	0.00118	CcSEcCtD
Methimazole—Dermatitis—Eplerenone—coronary artery disease	0.000175	0.00118	CcSEcCtD
Methimazole—Body temperature increased—Perindopril—coronary artery disease	0.000175	0.00118	CcSEcCtD
Methimazole—Headache—Eplerenone—coronary artery disease	0.000174	0.00117	CcSEcCtD
Methimazole—Thrombocytopenia—Ramipril—coronary artery disease	0.000174	0.00117	CcSEcCtD
Methimazole—Oedema—Timolol—coronary artery disease	0.000174	0.00117	CcSEcCtD
Methimazole—Pruritus—Pravastatin—coronary artery disease	0.000173	0.00117	CcSEcCtD
Methimazole—Nausea—Clopidogrel—coronary artery disease	0.000173	0.00117	CcSEcCtD
Methimazole—Vomiting—Simvastatin—coronary artery disease	0.000172	0.00116	CcSEcCtD
Methimazole—Nausea—Lovastatin—coronary artery disease	0.000172	0.00116	CcSEcCtD
Methimazole—Rash—Simvastatin—coronary artery disease	0.000171	0.00115	CcSEcCtD
Methimazole—Dermatitis—Simvastatin—coronary artery disease	0.000171	0.00115	CcSEcCtD
Methimazole—Urticaria—Furosemide—coronary artery disease	0.00017	0.00115	CcSEcCtD
Methimazole—Headache—Simvastatin—coronary artery disease	0.00017	0.00114	CcSEcCtD
Methimazole—Body temperature increased—Furosemide—coronary artery disease	0.00017	0.00114	CcSEcCtD
Methimazole—Nausea—Ezetimibe—coronary artery disease	0.000169	0.00114	CcSEcCtD
Methimazole—Pruritus—Trandolapril—coronary artery disease	0.000168	0.00113	CcSEcCtD
Methimazole—Arthralgia—Lisinopril—coronary artery disease	0.000168	0.00113	CcSEcCtD
Methimazole—Myalgia—Lisinopril—coronary artery disease	0.000168	0.00113	CcSEcCtD
Methimazole—Pruritus—Enalapril—coronary artery disease	0.000168	0.00113	CcSEcCtD
Methimazole—Pruritus—Telmisartan—coronary artery disease	0.000165	0.00111	CcSEcCtD
Methimazole—Nausea—Eplerenone—coronary artery disease	0.000165	0.00111	CcSEcCtD
Methimazole—Urticaria—Losartan—coronary artery disease	0.000164	0.00111	CcSEcCtD
Methimazole—Body temperature increased—Losartan—coronary artery disease	0.000164	0.0011	CcSEcCtD
Methimazole—Vomiting—Valsartan—coronary artery disease	0.000163	0.0011	CcSEcCtD
Methimazole—Vomiting—Olmesartan—coronary artery disease	0.000162	0.00109	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000162	0.00109	CcSEcCtD
Methimazole—Rash—Valsartan—coronary artery disease	0.000161	0.00109	CcSEcCtD
Methimazole—Dermatitis—Valsartan—coronary artery disease	0.000161	0.00109	CcSEcCtD
Methimazole—Nausea—Simvastatin—coronary artery disease	0.000161	0.00109	CcSEcCtD
Methimazole—Oedema—Lisinopril—coronary artery disease	0.000161	0.00109	CcSEcCtD
Methimazole—Pruritus—Captopril—coronary artery disease	0.000161	0.00108	CcSEcCtD
Methimazole—Rash—Olmesartan—coronary artery disease	0.000161	0.00108	CcSEcCtD
Methimazole—Dermatitis—Olmesartan—coronary artery disease	0.00016	0.00108	CcSEcCtD
Methimazole—Headache—Valsartan—coronary artery disease	0.00016	0.00108	CcSEcCtD
Methimazole—Headache—Olmesartan—coronary artery disease	0.00016	0.00108	CcSEcCtD
Methimazole—Paraesthesia—Ramipril—coronary artery disease	0.000159	0.00107	CcSEcCtD
Methimazole—Vomiting—Niacin—coronary artery disease	0.000158	0.00107	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000158	0.00107	CcSEcCtD
Methimazole—Somnolence—Ramipril—coronary artery disease	0.000158	0.00106	CcSEcCtD
Methimazole—Thrombocytopenia—Lisinopril—coronary artery disease	0.000158	0.00106	CcSEcCtD
Methimazole—Rash—Niacin—coronary artery disease	0.000157	0.00106	CcSEcCtD
Methimazole—Dermatitis—Niacin—coronary artery disease	0.000157	0.00106	CcSEcCtD
Methimazole—Dyspepsia—Ramipril—coronary artery disease	0.000156	0.00105	CcSEcCtD
Methimazole—Pruritus—Perindopril—coronary artery disease	0.000156	0.00105	CcSEcCtD
Methimazole—Headache—Niacin—coronary artery disease	0.000156	0.00105	CcSEcCtD
Methimazole—Paraesthesia—Timolol—coronary artery disease	0.000156	0.00105	CcSEcCtD
Methimazole—Vomiting—Pravastatin—coronary artery disease	0.000156	0.00105	CcSEcCtD
Methimazole—Rash—Pravastatin—coronary artery disease	0.000155	0.00104	CcSEcCtD
Methimazole—Dermatitis—Pravastatin—coronary artery disease	0.000154	0.00104	CcSEcCtD
Methimazole—Somnolence—Timolol—coronary artery disease	0.000154	0.00104	CcSEcCtD
Methimazole—Headache—Pravastatin—coronary artery disease	0.000154	0.00103	CcSEcCtD
Methimazole—Dyspepsia—Timolol—coronary artery disease	0.000153	0.00103	CcSEcCtD
Methimazole—Nausea—Valsartan—coronary artery disease	0.000152	0.00102	CcSEcCtD
Methimazole—Pruritus—Furosemide—coronary artery disease	0.000152	0.00102	CcSEcCtD
Methimazole—Nausea—Olmesartan—coronary artery disease	0.000151	0.00102	CcSEcCtD
Methimazole—Vomiting—Trandolapril—coronary artery disease	0.000151	0.00102	CcSEcCtD
Methimazole—Vomiting—Enalapril—coronary artery disease	0.000151	0.00102	CcSEcCtD
Methimazole—Rash—Trandolapril—coronary artery disease	0.00015	0.00101	CcSEcCtD
Methimazole—Dermatitis—Trandolapril—coronary artery disease	0.00015	0.00101	CcSEcCtD
Methimazole—Rash—Enalapril—coronary artery disease	0.000149	0.00101	CcSEcCtD
Methimazole—Dermatitis—Enalapril—coronary artery disease	0.000149	0.00101	CcSEcCtD
Methimazole—Headache—Trandolapril—coronary artery disease	0.000149	0.001	CcSEcCtD
Methimazole—Vomiting—Telmisartan—coronary artery disease	0.000149	0.001	CcSEcCtD
Methimazole—Headache—Enalapril—coronary artery disease	0.000149	0.001	CcSEcCtD
Methimazole—Nausea—Niacin—coronary artery disease	0.000148	0.000996	CcSEcCtD
Methimazole—Rash—Telmisartan—coronary artery disease	0.000147	0.000994	CcSEcCtD
Methimazole—Dermatitis—Telmisartan—coronary artery disease	0.000147	0.000993	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000147	0.000989	CcSEcCtD
Methimazole—Pruritus—Losartan—coronary artery disease	0.000146	0.000987	CcSEcCtD
Methimazole—Headache—Telmisartan—coronary artery disease	0.000146	0.000987	CcSEcCtD
Methimazole—Nausea—Pravastatin—coronary artery disease	0.000146	0.000981	CcSEcCtD
Methimazole—Paraesthesia—Lisinopril—coronary artery disease	0.000145	0.000974	CcSEcCtD
Methimazole—Vomiting—Captopril—coronary artery disease	0.000145	0.000974	CcSEcCtD
Methimazole—Rash—Captopril—coronary artery disease	0.000143	0.000966	CcSEcCtD
Methimazole—Dermatitis—Captopril—coronary artery disease	0.000143	0.000965	CcSEcCtD
Methimazole—Somnolence—Lisinopril—coronary artery disease	0.000143	0.000965	CcSEcCtD
Methimazole—Headache—Captopril—coronary artery disease	0.000142	0.00096	CcSEcCtD
Methimazole—Dyspepsia—Lisinopril—coronary artery disease	0.000142	0.000955	CcSEcCtD
Methimazole—Nausea—Trandolapril—coronary artery disease	0.000141	0.000953	CcSEcCtD
Methimazole—Urticaria—Ramipril—coronary artery disease	0.000141	0.000951	CcSEcCtD
Methimazole—Nausea—Enalapril—coronary artery disease	0.000141	0.000949	CcSEcCtD
Methimazole—Vomiting—Perindopril—coronary artery disease	0.00014	0.000946	CcSEcCtD
Methimazole—Body temperature increased—Ramipril—coronary artery disease	0.00014	0.000946	CcSEcCtD
Methimazole—Rash—Perindopril—coronary artery disease	0.000139	0.000938	CcSEcCtD
Methimazole—Dermatitis—Perindopril—coronary artery disease	0.000139	0.000937	CcSEcCtD
Methimazole—Nausea—Telmisartan—coronary artery disease	0.000139	0.000936	CcSEcCtD
Methimazole—Headache—Perindopril—coronary artery disease	0.000138	0.000932	CcSEcCtD
Methimazole—Urticaria—Timolol—coronary artery disease	0.000138	0.000929	CcSEcCtD
Methimazole—Body temperature increased—Timolol—coronary artery disease	0.000137	0.000925	CcSEcCtD
Methimazole—Vomiting—Furosemide—coronary artery disease	0.000136	0.00092	CcSEcCtD
Methimazole—Rash—Furosemide—coronary artery disease	0.000135	0.000912	CcSEcCtD
Methimazole—Dermatitis—Furosemide—coronary artery disease	0.000135	0.000911	CcSEcCtD
Methimazole—Nausea—Captopril—coronary artery disease	0.000135	0.00091	CcSEcCtD
Methimazole—Headache—Furosemide—coronary artery disease	0.000134	0.000906	CcSEcCtD
Methimazole—Vomiting—Losartan—coronary artery disease	0.000132	0.000887	CcSEcCtD
Methimazole—Nausea—Perindopril—coronary artery disease	0.000131	0.000884	CcSEcCtD
Methimazole—Rash—Losartan—coronary artery disease	0.000131	0.00088	CcSEcCtD
Methimazole—Dermatitis—Losartan—coronary artery disease	0.00013	0.000879	CcSEcCtD
Methimazole—Headache—Losartan—coronary artery disease	0.00013	0.000874	CcSEcCtD
Methimazole—Urticaria—Lisinopril—coronary artery disease	0.000128	0.000862	CcSEcCtD
Methimazole—Nausea—Furosemide—coronary artery disease	0.000127	0.000859	CcSEcCtD
Methimazole—Body temperature increased—Lisinopril—coronary artery disease	0.000127	0.000858	CcSEcCtD
Methimazole—Pruritus—Ramipril—coronary artery disease	0.000126	0.000847	CcSEcCtD
Methimazole—Nausea—Losartan—coronary artery disease	0.000123	0.000829	CcSEcCtD
Methimazole—Pruritus—Timolol—coronary artery disease	0.000123	0.000828	CcSEcCtD
Methimazole—Pruritus—Lisinopril—coronary artery disease	0.000114	0.000768	CcSEcCtD
Methimazole—Vomiting—Ramipril—coronary artery disease	0.000113	0.000761	CcSEcCtD
Methimazole—Rash—Ramipril—coronary artery disease	0.000112	0.000754	CcSEcCtD
Methimazole—Dermatitis—Ramipril—coronary artery disease	0.000112	0.000754	CcSEcCtD
Methimazole—Headache—Ramipril—coronary artery disease	0.000111	0.00075	CcSEcCtD
Methimazole—Vomiting—Timolol—coronary artery disease	0.00011	0.000744	CcSEcCtD
Methimazole—Rash—Timolol—coronary artery disease	0.000109	0.000738	CcSEcCtD
Methimazole—Dermatitis—Timolol—coronary artery disease	0.000109	0.000737	CcSEcCtD
Methimazole—Headache—Timolol—coronary artery disease	0.000109	0.000733	CcSEcCtD
Methimazole—Nausea—Ramipril—coronary artery disease	0.000105	0.000711	CcSEcCtD
Methimazole—Nausea—Timolol—coronary artery disease	0.000103	0.000695	CcSEcCtD
Methimazole—Vomiting—Lisinopril—coronary artery disease	0.000102	0.00069	CcSEcCtD
Methimazole—Rash—Lisinopril—coronary artery disease	0.000102	0.000684	CcSEcCtD
Methimazole—Dermatitis—Lisinopril—coronary artery disease	0.000101	0.000684	CcSEcCtD
Methimazole—Headache—Lisinopril—coronary artery disease	0.000101	0.00068	CcSEcCtD
Methimazole—Nausea—Lisinopril—coronary artery disease	9.56e-05	0.000645	CcSEcCtD
Methimazole—CYP2E1—Metabolism—HMOX1—coronary artery disease	5.29e-06	6.86e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP11B2—coronary artery disease	5.28e-06	6.84e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—TXNRD1—coronary artery disease	5.28e-06	6.84e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—AGT—coronary artery disease	5.24e-06	6.79e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CAT—coronary artery disease	5.22e-06	6.77e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—VCAN—coronary artery disease	5.22e-06	6.77e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SLC22A3—coronary artery disease	5.2e-06	6.73e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ALDOA—coronary artery disease	5.18e-06	6.71e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—APOB—coronary artery disease	5.18e-06	6.71e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—APOE—coronary artery disease	5.13e-06	6.65e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ARNTL—coronary artery disease	5.12e-06	6.64e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HADH—coronary artery disease	5.12e-06	6.64e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—APOA1—coronary artery disease	5.08e-06	6.58e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PSMA6—coronary artery disease	5.07e-06	6.57e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PSMB5—coronary artery disease	5.07e-06	6.57e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—APOB—coronary artery disease	5.07e-06	6.57e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GSTM1—coronary artery disease	5.03e-06	6.52e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—DCN—coronary artery disease	5.03e-06	6.52e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PSMB5—coronary artery disease	5.03e-06	6.52e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PSMA6—coronary artery disease	5.03e-06	6.52e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.02e-06	6.5e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CTGF—coronary artery disease	4.96e-06	6.42e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—LPL—coronary artery disease	4.94e-06	6.4e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GSTM1—coronary artery disease	4.93e-06	6.39e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CTGF—coronary artery disease	4.91e-06	6.37e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—HMGCR—coronary artery disease	4.91e-06	6.36e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GOT2—coronary artery disease	4.91e-06	6.36e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PLCB1—coronary artery disease	4.91e-06	6.36e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ALDH2—coronary artery disease	4.89e-06	6.34e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GOT2—coronary artery disease	4.87e-06	6.31e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—HMGCR—coronary artery disease	4.87e-06	6.31e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	4.86e-06	6.29e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—APOA2—coronary artery disease	4.86e-06	6.29e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GPX2—coronary artery disease	4.86e-06	6.29e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—LPL—coronary artery disease	4.84e-06	6.27e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GPX1—coronary artery disease	4.82e-06	6.25e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.82e-06	6.24e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SULT1A1—coronary artery disease	4.8e-06	6.21e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GPX4—coronary artery disease	4.8e-06	6.21e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ABCG5—coronary artery disease	4.8e-06	6.21e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HK1—coronary artery disease	4.8e-06	6.21e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	4.77e-06	6.18e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—LIPC—coronary artery disease	4.77e-06	6.18e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—HBA1—coronary artery disease	4.77e-06	6.18e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP2C19—coronary artery disease	4.77e-06	6.18e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	4.77e-06	6.18e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ABCA1—coronary artery disease	4.76e-06	6.17e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HADHA—coronary artery disease	4.74e-06	6.14e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—APOC3—coronary artery disease	4.74e-06	6.14e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GPX1—coronary artery disease	4.72e-06	6.12e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—LDLR—coronary artery disease	4.71e-06	6.1e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	4.7e-06	6.1e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CD36—coronary artery disease	4.7e-06	6.08e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTA1—coronary artery disease	4.68e-06	6.07e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SLC9A1—coronary artery disease	4.65e-06	6.03e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTT1—coronary artery disease	4.65e-06	6.03e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PPP2CA—coronary artery disease	4.64e-06	6.01e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—LPA—coronary artery disease	4.63e-06	6e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GOT1—coronary artery disease	4.61e-06	5.97e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GGT1—coronary artery disease	4.61e-06	5.97e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GCLC—coronary artery disease	4.6e-06	5.96e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CETP—coronary artery disease	4.6e-06	5.96e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CD36—coronary artery disease	4.6e-06	5.96e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SDC1—coronary artery disease	4.55e-06	5.89e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PPP2CA—coronary artery disease	4.54e-06	5.88e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PLCB1—coronary artery disease	4.52e-06	5.85e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PLCB3—coronary artery disease	4.49e-06	5.81e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PLCB1—coronary artery disease	4.48e-06	5.8e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PPARG—coronary artery disease	4.47e-06	5.79e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—MTHFR—coronary artery disease	4.45e-06	5.77e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—APOA5—coronary artery disease	4.44e-06	5.75e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—POMC—coronary artery disease	4.41e-06	5.71e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.39e-06	5.69e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ABCA1—coronary artery disease	4.38e-06	5.67e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—MTHFR—coronary artery disease	4.36e-06	5.65e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—P4HB—coronary artery disease	4.36e-06	5.64e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ABCA1—coronary artery disease	4.34e-06	5.62e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PSMA6—coronary artery disease	4.3e-06	5.57e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PSMB5—coronary artery disease	4.3e-06	5.57e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	4.29e-06	5.56e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	4.27e-06	5.54e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GOT1—coronary artery disease	4.24e-06	5.49e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GGT1—coronary artery disease	4.24e-06	5.49e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—AGT—coronary artery disease	4.23e-06	5.48e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GGT1—coronary artery disease	4.2e-06	5.45e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GOT1—coronary artery disease	4.2e-06	5.45e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CTGF—coronary artery disease	4.2e-06	5.44e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—HMGCR—coronary artery disease	4.16e-06	5.39e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GOT2—coronary artery disease	4.16e-06	5.39e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—APOE—coronary artery disease	4.14e-06	5.37e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—AGT—coronary artery disease	4.14e-06	5.37e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTP1—coronary artery disease	4.14e-06	5.36e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	4.1e-06	5.31e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—APOA1—coronary artery disease	4.09e-06	5.31e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—HMOX1—coronary artery disease	4.08e-06	5.29e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—APOE—coronary artery disease	4.06e-06	5.26e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—VCAN—coronary artery disease	4.03e-06	5.22e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CAT—coronary artery disease	4.03e-06	5.22e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—ALB—coronary artery disease	4.02e-06	5.21e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—APOA1—coronary artery disease	4.01e-06	5.2e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ALDOA—coronary artery disease	4e-06	5.18e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—APOB—coronary artery disease	3.91e-06	5.07e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—DCN—coronary artery disease	3.88e-06	5.03e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—NOS3—coronary artery disease	3.85e-06	4.98e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PLCB1—coronary artery disease	3.83e-06	4.96e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTP1—coronary artery disease	3.81e-06	4.93e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTM1—coronary artery disease	3.8e-06	4.93e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.78e-06	4.89e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTP1—coronary artery disease	3.77e-06	4.89e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	3.77e-06	4.89e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—HMOX1—coronary artery disease	3.76e-06	4.87e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.75e-06	4.86e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	3.74e-06	4.85e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—LPL—coronary artery disease	3.73e-06	4.84e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—HMOX1—coronary artery disease	3.72e-06	4.82e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ABCA1—coronary artery disease	3.71e-06	4.8e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CAT—coronary artery disease	3.71e-06	4.8e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—LIPC—coronary artery disease	3.68e-06	4.77e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HBA1—coronary artery disease	3.68e-06	4.77e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.68e-06	4.77e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.68e-06	4.77e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CAT—coronary artery disease	3.67e-06	4.76e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—APOC3—coronary artery disease	3.66e-06	4.74e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GPX1—coronary artery disease	3.64e-06	4.72e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—LDLR—coronary artery disease	3.63e-06	4.71e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PPARG—coronary artery disease	3.61e-06	4.68e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—APOB—coronary artery disease	3.6e-06	4.66e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.59e-06	4.65e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.59e-06	4.65e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GGT1—coronary artery disease	3.59e-06	4.65e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GOT1—coronary artery disease	3.59e-06	4.65e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—APOB—coronary artery disease	3.57e-06	4.62e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—POMC—coronary artery disease	3.56e-06	4.61e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GCLC—coronary artery disease	3.55e-06	4.6e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CETP—coronary artery disease	3.55e-06	4.6e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CD36—coronary artery disease	3.55e-06	4.6e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PPARG—coronary artery disease	3.53e-06	4.58e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTGS2—coronary artery disease	3.52e-06	4.56e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SDC1—coronary artery disease	3.51e-06	4.55e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PPP2CA—coronary artery disease	3.5e-06	4.54e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTM1—coronary artery disease	3.5e-06	4.53e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—POMC—coronary artery disease	3.49e-06	4.52e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTM1—coronary artery disease	3.47e-06	4.49e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—LPL—coronary artery disease	3.43e-06	4.45e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—LPL—coronary artery disease	3.4e-06	4.41e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—MTHFR—coronary artery disease	3.36e-06	4.36e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GPX1—coronary artery disease	3.35e-06	4.34e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GPX1—coronary artery disease	3.32e-06	4.3e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.32e-06	4.3e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.32e-06	4.3e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CD36—coronary artery disease	3.26e-06	4.23e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ALB—coronary artery disease	3.24e-06	4.2e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CTGF—coronary artery disease	3.24e-06	4.2e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CD36—coronary artery disease	3.24e-06	4.19e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTP1—coronary artery disease	3.23e-06	4.18e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PPP2CA—coronary artery disease	3.22e-06	4.18e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HMGCR—coronary artery disease	3.21e-06	4.16e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GOT2—coronary artery disease	3.21e-06	4.16e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	3.2e-06	4.14e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PPP2CA—coronary artery disease	3.19e-06	4.14e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—AGT—coronary artery disease	3.19e-06	4.14e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—HMOX1—coronary artery disease	3.18e-06	4.12e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ALB—coronary artery disease	3.18e-06	4.12e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CAT—coronary artery disease	3.14e-06	4.07e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—APOE—coronary artery disease	3.13e-06	4.06e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—NOS3—coronary artery disease	3.1e-06	4.02e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—APOA1—coronary artery disease	3.09e-06	4.01e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—MTHFR—coronary artery disease	3.09e-06	4.01e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—MTHFR—coronary artery disease	3.07e-06	3.97e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—APOB—coronary artery disease	3.05e-06	3.95e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—NOS3—coronary artery disease	3.04e-06	3.94e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTM1—coronary artery disease	2.96e-06	3.84e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.96e-06	3.84e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.95e-06	3.83e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—AGT—coronary artery disease	2.94e-06	3.81e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—AGT—coronary artery disease	2.91e-06	3.77e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—LPL—coronary artery disease	2.91e-06	3.77e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—APOE—coronary artery disease	2.88e-06	3.73e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.86e-06	3.71e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—APOE—coronary artery disease	2.85e-06	3.7e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—APOA1—coronary artery disease	2.85e-06	3.69e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GPX1—coronary artery disease	2.84e-06	3.68e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTGS2—coronary artery disease	2.84e-06	3.68e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—APOA1—coronary artery disease	2.82e-06	3.66e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTGS2—coronary artery disease	2.78e-06	3.6e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GOT1—coronary artery disease	2.77e-06	3.59e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GGT1—coronary artery disease	2.77e-06	3.59e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CD36—coronary artery disease	2.76e-06	3.58e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PPP2CA—coronary artery disease	2.73e-06	3.54e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PPARG—coronary artery disease	2.73e-06	3.53e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.7e-06	3.5e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—POMC—coronary artery disease	2.69e-06	3.48e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—MTHFR—coronary artery disease	2.62e-06	3.39e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PPARG—coronary artery disease	2.51e-06	3.25e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.49e-06	3.23e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—AGT—coronary artery disease	2.49e-06	3.23e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PPARG—coronary artery disease	2.49e-06	3.22e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—POMC—coronary artery disease	2.47e-06	3.2e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.47e-06	3.2e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.46e-06	3.18e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—POMC—coronary artery disease	2.45e-06	3.18e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ALB—coronary artery disease	2.45e-06	3.18e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—APOE—coronary artery disease	2.44e-06	3.16e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CAT—coronary artery disease	2.42e-06	3.14e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—APOA1—coronary artery disease	2.41e-06	3.12e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—APOB—coronary artery disease	2.35e-06	3.05e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—NOS3—coronary artery disease	2.35e-06	3.04e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.31e-06	2.99e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.29e-06	2.96e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ALB—coronary artery disease	2.25e-06	2.92e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—LPL—coronary artery disease	2.25e-06	2.91e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ALB—coronary artery disease	2.24e-06	2.9e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GPX1—coronary artery disease	2.19e-06	2.84e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CA—coronary artery disease	2.16e-06	2.8e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NOS3—coronary artery disease	2.16e-06	2.79e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTGS2—coronary artery disease	2.14e-06	2.78e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NOS3—coronary artery disease	2.14e-06	2.77e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CD36—coronary artery disease	2.13e-06	2.76e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PPARG—coronary artery disease	2.12e-06	2.75e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.11e-06	2.73e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—POMC—coronary artery disease	2.1e-06	2.71e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.02e-06	2.62e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.97e-06	2.56e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.96e-06	2.53e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—AGT—coronary artery disease	1.92e-06	2.49e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ALB—coronary artery disease	1.91e-06	2.48e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—APOE—coronary artery disease	1.88e-06	2.44e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—APOA1—coronary artery disease	1.86e-06	2.41e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NOS3—coronary artery disease	1.83e-06	2.37e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—AKT1—coronary artery disease	1.77e-06	2.29e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CA—coronary artery disease	1.75e-06	2.26e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CA—coronary artery disease	1.71e-06	2.22e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.67e-06	2.17e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PPARG—coronary artery disease	1.64e-06	2.12e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—POMC—coronary artery disease	1.62e-06	2.1e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ALB—coronary artery disease	1.47e-06	1.91e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—AKT1—coronary artery disease	1.43e-06	1.85e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NOS3—coronary artery disease	1.41e-06	1.83e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—AKT1—coronary artery disease	1.4e-06	1.81e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CA—coronary artery disease	1.32e-06	1.71e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.29e-06	1.67e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.21e-06	1.57e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CA—coronary artery disease	1.2e-06	1.56e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—AKT1—coronary artery disease	1.08e-06	1.4e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CA—coronary artery disease	1.03e-06	1.33e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—AKT1—coronary artery disease	9.91e-07	1.28e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—AKT1—coronary artery disease	9.83e-07	1.27e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—AKT1—coronary artery disease	8.4e-07	1.09e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CA—coronary artery disease	7.93e-07	1.03e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—AKT1—coronary artery disease	6.48e-07	8.4e-06	CbGpPWpGaD
